Inside The Most Promising Non-Viral Approaches For Genetic Engineering

It's no secret that ongoing research aims to improve the efficacy and specificity of non-viral approaches for genetic engineering. But the field is rapidly evolving with research aimed at improving transfection efficiency, targeting, and safety profiles of non-viral delivery systems. 

In this Cell & Gene Live digital event, Robert Hariri, M.D., Ph.D., Chairman and CEO at Celularity, and Paul Kopesky, Ph.D., VP of Cell Therapy Process Development at Beam Therapeutics, joined host Erin Harris to discuss the most notable non-viral approaches and recent breakthroughs in genetic engineering, as well as promising non-viral vectors used in clinical trials.

Available on-demand thanks to the support of MaxCyte.

Don't have time to watch the full video? Check out these segments by topic:

• Non-Viral Tools For Genome Engineering
• Safety And Efficacy Advancements In Genome Editing
• Base Editing's Advantages When Combined With Non-Viral Delivery Methods
• NK Cells' Role In Non-Viral Approaches To Genetic Engineering
• Electroporation As A Method For Genetic Modification
• Audience Q&A